Eleven Biotherapeutics reported $-807000 in Net Income for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Amgen AMGN:US $ 1317M 159M
Bayer BAYN:GR € -298M 3589M
Bristol Myers Squibb BMY:US $ 1421M 143M
Corcept Therapeutics CORT:US $ 27.41M 4.62M
Eleven Biotherapeutics EBIO:US $ -0.81M 9.75M
Eli Lilly And LLY:US $ 952.5M 950.4M
Merk MRK:US $ 3944M 366M
Pfizer PFE:US $ 9905M 2042M
Rigel Pharmaceuticals RIGL:US $ -13.49M 13.95M
Ziopharm Oncology ZIOP:US $ -9.93M 0.14M